Microbot Medical Inc. Announces Closing of $9.59 Million Registered Direct Offering of Common Stock
December 27, 2019 10:00 ET
|
Microbot Medical
HINGHAM, Mass., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT) closed its previously announced registered direct offering of 912,858 shares of its common stock at a purchase...
Microbot Medical Inc. Announces $9.59 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
December 26, 2019 06:00 ET
|
Microbot Medical
HINGHAM, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical...
Microbot Medical to Unveil World’s First Fully Disposable Robotic System for Endovascular Procedures
December 23, 2019 07:00 ET
|
Microbot Medical
Live Demonstration Planned for Monday, January 13, 2020, in San FranciscoBreakthrough technology features compact design, remote operation capabilities and an integrated “One & Done” tool to...
Global Jurisdictions Continue to Recognize Microbot Medical’s Innovative Technology; Receives Notice of Allowance for a U.S. Patent Covering its TipCAT™ Technology Platform
November 25, 2019 07:00 ET
|
Microbot Medical
HINGHAM, Mass., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Further demonstrating its commitment to expand and protect its Intellectual Property (IP) portfolio, Microbot Medical Inc. (Nasdaq: MBOT) was issued...
Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT™ Technology Platform
October 30, 2019 07:00 ET
|
Microbot Medical
HINGHAM, Mass., Oct. 30, 2019 (GLOBE NEWSWIRE) -- In an expansion of its significant global patent estate, Microbot Medical Inc. (Nasdaq: MBOT) announced that the U.S. Patent and Trademark Office...
Microbot Medical Announces Outcome of Annual Meeting of Shareholders
September 13, 2019 07:30 ET
|
Microbot Medical
Maintains Regulatory Pre-Submission Timeline of the Self-Cleaning Shunt (SCS TM) HINGHAM, Mass., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Having successfully executed a number of significant milestones...
Microbot Medical’s Self-Cleaning Shunt (SCS™) Clearly Demonstrated the Ability to Prevent Shunt Occlusion in a Follow-up In-vitro Laboratory Study
September 10, 2019 07:30 ET
|
Microbot Medical
HINGHAM, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Having successfully concluded an independent in-vitro laboratory study and published the positive results earlier this year, the operational...
Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference
September 05, 2019 16:05 ET
|
Microbot Medical
HINGHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- At the upcoming Rodman & Renshaw Global Investment Conference, Harel Gadot, CEO, President and Chairman of Microbot Medical Inc. (Nasdaq:...
Microbot Medical Receives Notice of Allowance from the Israel Patent Office for a Patent Application covering a System for Reducing Dialysis Shunt Stenosis
July 24, 2019 07:30 ET
|
Microbot Medical
HINGHAM, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- As it continues to expand and diversify its Intellectual Property (IP) portfolio, Microbot Medical (Nasdaq: MBOT) announced that it has received a...
Microbot Medical Strengthens Global IP Portfolio with Canadian Notice of Allowance for a Patent Application for a Shunt Stenosis Prevention System
April 23, 2019 07:00 ET
|
Microbot Medical
HINGHAM, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- As it continues to receive an overwhelming positive response from global jurisdictions, Microbot Medical Inc. (NASDAQ: MBOT) expands its IP...